163 related articles for article (PubMed ID: 19181417)
21. Clinical usefulness of the fluorodeoxyglucose (FDG)-PET maximal standardized uptake value (SUV) in combination with CT features for the differentiation of adenocarcinoma with a bronchioloalveolar carcinoma from other subtypes of non-small cell lung cancers.
Sun JS; Park KJ; Sheen SS; Yoon JK; Yoon SN; Lee KB; Hwang SC
Lung Cancer; 2009 Nov; 66(2):205-10. PubMed ID: 19203812
[TBL] [Abstract][Full Text] [Related]
22. A proliferation-inducing ligand: a new biomarker for non-small cell lung cancer.
Sun B; Wang H; Wang X; Huang H; Ding W; Jing R; Shi G; Zhu L
Exp Lung Res; 2009 Aug; 35(6):486-500. PubMed ID: 19842833
[TBL] [Abstract][Full Text] [Related]
23. Identification of ten serum microRNAs from a genome-wide serum microRNA expression profile as novel noninvasive biomarkers for nonsmall cell lung cancer diagnosis.
Chen X; Hu Z; Wang W; Ba Y; Ma L; Zhang C; Wang C; Ren Z; Zhao Y; Wu S; Zhuang R; Zhang Y; Hu H; Liu C; Xu L; Wang J; Shen H; Zhang J; Zen K; Zhang CY
Int J Cancer; 2012 Apr; 130(7):1620-8. PubMed ID: 21557218
[TBL] [Abstract][Full Text] [Related]
24. IL-2, TNF-alpha, and leptin: local versus systemic concentrations in NSCLC patients.
Carpagnano GE; Spanevello A; Curci C; Salerno F; Palladino GP; Resta O; Di Gioia G; Carpagnano F; Foschino Barbaro MP
Oncol Res; 2007; 16(8):375-81. PubMed ID: 17913045
[TBL] [Abstract][Full Text] [Related]
25. Blood test shows high accuracy in detecting stage I non-small cell lung cancer.
Goebel C; Louden CL; Mckenna R; Onugha O; Wachtel A; Long T
BMC Cancer; 2020 Feb; 20(1):137. PubMed ID: 32085733
[TBL] [Abstract][Full Text] [Related]
26. Serum microRNA Signature Is Capable of Early Diagnosis for Non-Small Cell Lung Cancer.
Yang X; Zhang Q; Zhang M; Su W; Wang Z; Li Y; Zhang J; Beer DG; Yang S; Chen G
Int J Biol Sci; 2019; 15(8):1712-1722. PubMed ID: 31360113
[TBL] [Abstract][Full Text] [Related]
27. Monitoring non-small cell lung cancer progression and treatment response through hyaluronic acid in sputum.
Chinoca J; Andrade DS; Mendes A; Marchi P; Prieto TG; Baldavira CM; Farhat C; Martins JRM; Nader HB; Carraro DM; Capelozzi VL; Sá V
Braz J Med Biol Res; 2022; 55():e11513. PubMed ID: 35320334
[TBL] [Abstract][Full Text] [Related]
28. Sequential screening for lung cancer in a high-risk group: randomised controlled trial: LungSEARCH: a randomised controlled trial of Surveillance using sputum and imaging for the EARly detection of lung Cancer in a High-risk group.
Spiro SG; Shah PL; Rintoul RC; George J; Janes S; Callister M; Novelli M; Shaw P; Kocjan G; Griffiths C; Falzon M; Booton R; Magee N; Peake M; Dhillon P; Sridharan K; Nicholson AG; Padley S; Taylor MN; Ahmed A; Allen J; Ngai Y; Chinyanganya N; Ashford-Turner V; Lewis S; Oukrif D; Rabbitts P; Counsell N; Hackshaw A
Eur Respir J; 2019 Oct; 54(4):. PubMed ID: 31537697
[TBL] [Abstract][Full Text] [Related]
29. Early detection of lung cancers - Comparison of computed tomography, cytology and fuzzy-based tumor markers panels.
Schneider J
Cancer Biomark; 2010; 6(3-4):149-62. PubMed ID: 20660961
[TBL] [Abstract][Full Text] [Related]
30. Positron emission tomography combined with diagnostic chest computed tomography enhances detection of regional recurrence after stereotactic body radiation therapy for early stage non-small cell lung cancer.
Ebright MI; Russo GA; Gupta A; Subramaniam RM; Fernando HC; Kachnic LA
J Thorac Cardiovasc Surg; 2013 Mar; 145(3):709-15. PubMed ID: 23317944
[TBL] [Abstract][Full Text] [Related]
31. Computed Tomography Histogram Approach to Predict Lymph Node Metastasis in Patients With Clinical Stage IA Lung Cancer.
Shimada Y; Kudo Y; Furumoto H; Imai K; Maehara S; Tanaka T; Shigefuku S; Hagiwara M; Masuno R; Yamada T; Kakihana M; Kajiwara N; Ohira T; Ikeda N
Ann Thorac Surg; 2019 Oct; 108(4):1021-1028. PubMed ID: 31207242
[TBL] [Abstract][Full Text] [Related]
32. [Influence of computed tomography of the abdomen for staging lung cancer].
Maya Martínez M; Carrión Valero F; Díaz López J; Mollá Landete MA; Marín Pardo J
Arch Bronconeumol; 2002 Mar; 38(3):123-9. PubMed ID: 11900689
[TBL] [Abstract][Full Text] [Related]
33. Detection of circulating genetically abnormal cells in peripheral blood for early diagnosis of non-small cell lung cancer.
Liu WR; Zhang B; Chen C; Li Y; Ye X; Tang DJ; Zhang JC; Ma J; Zhou YL; Fan XJ; Yue DS; Li CG; Zhang H; Ma YC; Huo YS; Zhang ZF; He SY; Wang CL
Thorac Cancer; 2020 Nov; 11(11):3234-3242. PubMed ID: 32989915
[TBL] [Abstract][Full Text] [Related]
34. A panel of promoter methylation markers for invasive and noninvasive early detection of NSCLC using a quantum dots-based FRET approach.
Ma Y; Bai Y; Mao H; Hong Q; Yang D; Zhang H; Liu F; Wu Z; Jin Q; Zhou H; Cao J; Zhao J; Zhong X; Mao H
Biosens Bioelectron; 2016 Nov; 85():641-648. PubMed ID: 27240011
[TBL] [Abstract][Full Text] [Related]
35. Diagnosis of roentgenographically occult lung cancer by sputum cytology.
Petty TL; Tockman MS; Palcic B
Clin Chest Med; 2002 Mar; 23(1):59-64. PubMed ID: 11901920
[TBL] [Abstract][Full Text] [Related]
36. Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: accuracy of integrated positron emission tomography and computed tomography.
Billé A; Pelosi E; Skanjeti A; Arena V; Errico L; Borasio P; Mancini M; Ardissone F
Eur J Cardiothorac Surg; 2009 Sep; 36(3):440-5. PubMed ID: 19464906
[TBL] [Abstract][Full Text] [Related]
37. Impact of 18F-FDG PET/CT in the treatment of patients with non-small cell lung cancer.
Taus Á; Aguiló R; Curull V; Suárez-Piñera M; Rodríguez-Fuster A; Rodríguez de Dios N; Pijuan L; Zuccarino F; Vollmer I; Sánchez-Font A; Belda-Sanchis J; Arriola E
Arch Bronconeumol; 2014 Mar; 50(3):99-104. PubMed ID: 24360985
[TBL] [Abstract][Full Text] [Related]
38. PET, CT, and MRI with Combidex for mediastinal staging in non-small cell lung carcinoma.
Kernstine KH; Stanford W; Mullan BF; Rossi NP; Thompson BH; Bushnell DL; McLaughlin KA; Kern JA
Ann Thorac Surg; 1999 Sep; 68(3):1022-8. PubMed ID: 10510001
[TBL] [Abstract][Full Text] [Related]
39. Comparing the Diagnostic Potential of 68Ga-Alfatide II and 18F-FDG in Differentiating Between Non-Small Cell Lung Cancer and Tuberculosis.
Kang F; Wang S; Tian F; Zhao M; Zhang M; Wang Z; Li G; Liu C; Yang W; Li X; Wang J
J Nucl Med; 2016 May; 57(5):672-7. PubMed ID: 26719378
[TBL] [Abstract][Full Text] [Related]
40. Combined contrast-enhanced computed tomography and 18-fluoro-2-deoxy-D-glucose-positron emission tomography in the diagnosis and staging of non-small cell lung cancer.
Allen TL; Kendi AT; Mitiek MO; Maddaus MA
Semin Thorac Cardiovasc Surg; 2011; 23(1):43-50. PubMed ID: 21807298
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
